A Look into the Bioscientific Endeavors of medicines of Jeff Aronin

Jeff Aronin has been very successful in leading many pharmaceutical companies with finding novel treatments for patients and their families. His dedication to continuously assist in the progress in providing vital medicines to families who need it the most is highly commendable. His partnership with Paragon is eagerly anticipated with further studies of biosciences in creation for newer medicines that focuses on some of the more rare diseases that do not affect the greater population. His strong work ethic and shared belief in Paragon philosophy of helping as many patients as possible, even ones who generally are overlooked due to the rarity of their illness has led him to receive several accolades and honors during his career even before the collaboration with Paragon and other start up pharmaceutical he has had a huge part in. Some of his most recent awards includes the Weizmann Leadership Award, The Frederic A. Gibbs Discovery Award and even the Deal Of The Year accolade from the Buyouts in 2010. He was also one of the Entrepreneur of the year finalist by Ernst & Young within his geographical area in 2006.

 

Jeff Aronin has supported many companies all over the globe throughout the years, constantly showcasing his passion in developing and maintaining the next generation of healthcare leaders. Some of the organizations Jeff has been known to provide his expertise and support to are the Juvenile Diabetes Research, the prominent Susan G. Komen organization and Cystic Fibrosis Foundation, just to name a few. He is also the leading participate in many of the start up companies that are in the inception stages in Chicago. It’s very interesting to see what plans Jeff has in store for his future endeavors with leading, educating, and improving lives in the bioscience industry with finding innovative ways to bring essential medicines to many individuals and their families.

 

Leave a Reply

Your email address will not be published. Required fields are marked *